跳轉至內容
Merck
全部照片(1)

重要文件

1269232

USP

Famotidine Related Compound C

United States Pharmacopeia (USP) Reference Standard

同義詞:

3-[[[2-[(Aminoiminomethyl)amino]-4-thiazolyl]methyl]thio]-N-(aminosulfonyl)propanamide monohydrochloride, 3-{[2-(Diaminomethyleneamino)thiazol-4-yl]methylthio}-N-sulfamoylpropanamide hydrochloride

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C8H14N6O3S3 · HCl
CAS號碼:
分子量::
374.89
MDL號碼:
分類程式碼代碼:
41116107
NACRES:
NA.24
暫時無法取得訂價和供貨情況

生物源

synthetic

等級

pharmaceutical primary standard

agency

USP

API 家族

famotidine

形狀

powder

包裝

pkg of 25 mg

製造商/商標名

USP

儲存條件

protect from light

顏色

white to off-white

mp

298.4-314.6 °F (148—157°C)

應用

pharmaceutical (small molecule)

形式

neat

儲存溫度

2-8°C

SMILES 字串

[S](=O)(=O)(NC(=O)CCSCc1nc([s]c1)N\C(=N/[H])\N)N.Cl

InChI

1S/C8H14N6O3S3.ClH/c9-7(10)13-8-12-5(4-19-8)3-18-2-1-6(15)14-20(11,16)17;/h4H,1-3H2,(H,14,15)(H2,11,16,17)(H4,9,10,12,13);1H

InChI 密鑰

LBBLJRHWJZWHQA-UHFFFAOYSA-N

一般說明

Famotidine Related Compound C (Famotidine Impurity C) is an impurity of famotidine, which is a hydrophilic, cationic, histamine H2 receptor antagonist drug that effectively inhibits gastric acid secretion in humans.[1][2][3]
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

分析報告

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

其他說明

Sales restrictions may apply.

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable


從最近期的版本中選擇一個:

分析證明 (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如果您需要協助,請聯絡 客戶支援

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Famotidine
Pharmacopeia, US
United States Pharmacopeia, 39(1)(1-2), 1815-1815 (2020)
Stability indicating method for famotidine in pharmaceuticals using porous graphitic carbon column
Helali N and Monser L
Journal of Separation Science, 31(2) (2008)
RP-HPLC determination of famotidine and its potential impurities in pharmaceuticals
Helali N, et al.
Chromatographia, 60(7-8) (2004)
Capillary zone electrophoresis method for the determination of famotidine and related impurities in pharmaceuticals
Helali N, et al.
Talanta, 74(4) (2008)
Development and validation of chromatographic methods for simultaneous determination of ibuprofen and famotidine in presence of related substances in pharmaceutical formulations
Elzanfaly ES, et al.
Acta Chimica Slovenica, 62(1) (2014)

Questions

Reviews

No rating value

Active Filters

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務